Search research articles
Contact Us
Filters
Showing results (521-530 of 602) with videos related to
Page
of 61
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 15, 2015
Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein
Lora D Weidner, King Leung Fung, Pavitra Kannan, et al.
Journal of Medicinal Chemistry
|
February 5, 2020
Retraction of "Collateral Sensitivity of Multidrug-Resistant Cells to the Orphan Drug Tiopronin"
Andrew S Goldsborough, Misty D Handley, Andres E Dulcey, et al.
Cancer
|
May 16, 2013
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity
Chirayu Patel, Leif Stenke, Sudhir Varma, et al.
Journal of the National Cancer Institute
|
August 26, 2009
Influence of melanosome dynamics on melanoma drug sensitivity
Kevin G Chen, Richard D Leapman, Guofeng Zhang, et al.
Experimental Cell Research
|
January 20, 2004
Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells
Xing-Jie Liang, Jun-Jie Yin, Jien-Wei Zhou, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
September 2, 2015
Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs
Justin C Jagodinsky, Agnieszka Sulima, Yiqi Cao, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 5, 2016
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter
Pavitra Kannan, Martin Schain, Warren W Kretzschmar, et al.
Journal of the National Cancer Institute
|
October 12, 2010
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics
Anna Maria Calcagno, Crystal D Salcido, Jean-Pierre Gillet, et al.
Journal of Medicinal Chemistry
|
April 29, 2009
Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells
Matthew D Hall, Noeris K Salam, Jennifer L Hellawell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 8, 2015
The Inhibitor Ko143 Is Not Specific for ABCG2
Lora D Weidner, Sami S Zoghbi, Shuiyu Lu, et al.
Page
of 61
Search research articles
Search
Showing results (521-530 of 602) with videos related to
Sort By:
Page
of 61
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 15, 2015
Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein
Lora D Weidner, King Leung Fung, Pavitra Kannan, et al.
Journal of Medicinal Chemistry
|
February 5, 2020
Retraction of "Collateral Sensitivity of Multidrug-Resistant Cells to the Orphan Drug Tiopronin"
Andrew S Goldsborough, Misty D Handley, Andres E Dulcey, et al.
Cancer
|
May 16, 2013
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity
Chirayu Patel, Leif Stenke, Sudhir Varma, et al.
Journal of the National Cancer Institute
|
August 26, 2009
Influence of melanosome dynamics on melanoma drug sensitivity
Kevin G Chen, Richard D Leapman, Guofeng Zhang, et al.
Experimental Cell Research
|
January 20, 2004
Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells
Xing-Jie Liang, Jun-Jie Yin, Jien-Wei Zhou, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
September 2, 2015
Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs
Justin C Jagodinsky, Agnieszka Sulima, Yiqi Cao, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 5, 2016
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter
Pavitra Kannan, Martin Schain, Warren W Kretzschmar, et al.
Journal of the National Cancer Institute
|
October 12, 2010
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics
Anna Maria Calcagno, Crystal D Salcido, Jean-Pierre Gillet, et al.
Journal of Medicinal Chemistry
|
April 29, 2009
Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells
Matthew D Hall, Noeris K Salam, Jennifer L Hellawell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 8, 2015
The Inhibitor Ko143 Is Not Specific for ABCG2
Lora D Weidner, Sami S Zoghbi, Shuiyu Lu, et al.
Page
of 61